Differential Effects of Progenitor Cell Populations on Myocardial Neovascularization and Left Ventricular Remodeling after Myocardial Infarction
Christophe Dubois(KU Leuven), Stefan Janssens(Maastricht University), Hilde Gillijns(Ghent University), Marinee Chua(VIB-KU Leuven Center for Microbiology), Frederik Maes(Universitair Ziekenhuis Leuven), Xiashun Liu(KU Leuven), Hélène Depelteau(Universitair Ziekenhuis Leuven), Glenn Marsboom(Johnson & Johnson (United States)), Frans Van de Werf(KU Leuven), Jan Bogaert(KU Leuven), Lertlak Chaothawee(Universitair Ziekenhuis Leuven), Thierry VandenDriessche(Vrije Universiteit Brussel), Marijke Pellens(Ghent University), Péter Pokreisz(Ghent University), Désiré Collen(Ghent University), Witold Streb
Lirias
October 28, 2008
Cited by 0
Related Papers
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
|Nature|1996|4.2k
Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both
|New England Journal of Medicine|2003|2.5k
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
|Nature Medicine|2001|1.7k
Dabigatran versus Warfarin in Patients with Mechanical Heart Valves
|New England Journal of Medicine|2013|1.5k